Effects of the luteinizing-hormone-releasing hormone (LHRH) antagonist ramorelix (hoe013) and the LHRH agonist buserelin on dimethylbenz[a]anthracene-induced mammary carcinoma: studies with slow-release formulations
1993 ◽
Vol 119
(8)
◽
pp. 457-462
◽
2002 ◽
Vol 99
(23)
◽
pp. 15048-15053
◽
2001 ◽
Vol 98
(21)
◽
pp. 12197-12202
◽
1991 ◽
Vol 38
(2)
◽
pp. 119-126
◽
1989 ◽
Vol 115
(1)
◽
pp. 105-108
◽
1992 ◽
Vol 118
(1)
◽
pp. 44-49
◽
1984 ◽
Vol 91
(9)
◽
pp. 913-916
◽